Literature DB >> 3004232

Supply-to-demand ratio for oxygen determines formation of adenosine by the heart.

H Bardenheuer, J Schrader.   

Abstract

To investigate the basic mechanism for formation of adenosine, cardiac work was increased using an isolated guinea pig working heart preparation. Cardiac metabolism was stimulated by intracoronary infusion of isoproterenol, norepinephrine (NE), ouabain, and the cardiotonic agent 1H-imidazo[4,5-b]pyridine, 2-[2-methoxy-4-(methylsulfinyl)-phenyl] (AR-L 115), and the release of adenosine into the effluent was determined. Besides their inotropic effects on myocardial tissue, these substances affect differently the tone of coronary arteries. Thus they influence the supply-to-demand ratio for O2 and the tissue cyclic AMP content differently. When myocardial O2 consumption was increased to the same extent, the changes in coronary flow induced followed the order of AR-L 115 greater than isoproterenol greater than NE greater than ouabain. Conversely, the rank order of potency causing adenosine and inosine release was NE greater than ouabain greater than isoproterenol greater than AR-L 115. When NE-induced vasoconstriction was abolished by prazosin, the release of adenosine and inosine was significantly diminished. Enhancement of O2 supply by overperfusion of the coronary arteries in isoproterenol-stimulated hearts was associated with a significant reduction of nucleoside release into the effluent. Our findings suggest that the major stimulus for myocardial adenosine formation is an imbalance between O2 delivery and O2 demand and not the metabolic rate as such. In the isolated heart, adenosine is formed as a feedback signal and can compete with NE- and ouabain-induced vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004232     DOI: 10.1152/ajpheart.1986.250.2.H173

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

1.  Tonic activity of the rat adipocyte A1-adenosine receptor.

Authors:  Hui-Xiu Liang; Luiz Belardinelli; Mark J Ozeck; John C Shryock
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Capillary endothelial transport of uric acid in guinea pig heart.

Authors:  K Kroll; T R Bukowski; L M Schwartz; D Knoepfler; J B Bassingthwaighte
Journal:  Am J Physiol       Date:  1992-02

3.  Effect of changes in renal circulation on serum uric acid levels in women with twin pregnancy.

Authors:  Miwa Igarashi; Hidehiko Miyake; Shunji Suzuki
Journal:  Clin Exp Nephrol       Date:  2010-06-17       Impact factor: 2.801

Review 4.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

Review 5.  Lactic acidosis in sepsis: a commentary.

Authors:  G Gutierrez; M E Wulf
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

Review 6.  Profile of an ideal antianginal agent.

Authors:  E J Lazar; W H Frishman
Journal:  Drugs       Date:  1989       Impact factor: 9.546

7.  The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart.

Authors:  H G Lloyd; A Deussen; H Wuppermann; J Schrader
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

Review 8.  Alpha 1-adrenergic tone does not influence the transmural distribution of myocardial blood flow during exercise in dogs with pressure overload left ventricular hypertrophy.

Authors:  D J Duncker; J Zhang; M J Crampton; R J Bache
Journal:  Basic Res Cardiol       Date:  1995 Jan-Feb       Impact factor: 17.165

9.  Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.

Authors:  M D Randall; H Ujiie; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

10.  Endogenous adenosine is an autacoid feedback inhibitor of chloride transport in the shark rectal gland.

Authors:  G G Kelley; O S Aassar; J N Forrest
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.